Over a median follow-up of 5.5 years, people in the Atherosclerosis Risk in Communities (ARIC) cohort who used prescribed PPIs for more than 4.4 years had a higher risk of dementia (adjusted HR 1.3, ...
Proton pump inhibitors (PPIs) — used widely to reduce stomach acid and treat heartburn — have been linked to an increased risk for ischemic stroke in a new study. The Danish nationwide observational ...
Millions of Americans take medications known as proton pump inhibitors every day to treat heartburn and acid reflux, and in recent years, these drugs, also known as PPIs, have been linked to a greater ...
August 24, 2011 — The nonprofit consumer advocacy group Public Citizen is petitioning the US Food and Drug Administration (FDA) to add black box warnings to the product labels of all proton pump ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
NEW YORK (Reuters Health) - Long-term use of proton pump inhibitors (PPIs)--drugs such as Prilosec (omeprazole) and Prevacid (lansoprazole) that are used to stop stomach acid from "refluxing" into the ...
People taking common heartburn and indigestion medicines may face a heightened risk of premature death, according to new observational research published Monday in the "British Medical Journal Open." ...
One of the largest-ever studies on the topic of deprescribing medications shows the potential promise, and pitfalls, of a massive effort to reduce overuse of a common class of heartburn medications ...
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback